Sarbani Chaudhuri
Patrimonio netto: 817 336 $ in data 31/07/2026
Patrimonio netto: 817 336 $ in data 31/07/2026
Sarbani Chaudhuri is currently Chief Commercial & Medical Affairs Officer at Rocket Pharmaceuticals, Inc. since 2025.
Former positions include Vice President at Johnson & Johnson from 2022 to 2025 and Principal at AstraZeneca, Inc. from 2020 to 2021.
Education includes an MBA from the University of Pennsylvania, graduate studies at Xavier School of Management, and undergraduate studies at Veermata Jijabai Technological Institute.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/08/2026 | 262.809 ( 0,24% ) | 817 336 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 07/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/03/2025 |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | 01/11/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veermata Jijabai Technological Institute
Veermata Jijabai Technological Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xavier School of Management
Xavier School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale